Weekly Spotlight - 14.11.24

Community Voices

We want to hear your story!

Fill in the form if you would like to be featured in one of our weekly newsletters! Share your experiences, challenges you’ve faced and any advice that you might have for others in your community.

In the News

Wayne Bayley's Tragic Death Highlights Urgent Need for Prison Reform

Wayne Bayley, a Black man living with sickle cell disease, died in prison after experiencing a medical crisis that was met with inadequate care. An inquest determined that failures in providing adequate response and restraint contributed significantly to his death. His family, deeply affected by this loss, have urged for meaningful reforms in the treatment of vulnerable prisoners and greater awareness of the severe impact of sickle cell disease to prevent future tragedies.

Sickle Cell Study Compares Symptom Treatments with Transplant Options

The University of Rochester's Golisano Children's Hospital is conducting a study comparing sickle cell disease treatments. It will assess symptom management therapies like blood transfusions and hydroxyurea against curative options like bone marrow transplants. The study aims to guide families in making informed treatment decisions for their children.

Sickle Cell Struggles: Tammy Clemons' Journey of Pain and Resilience

Tammy Clemons, a sickle cell patient, navigates the challenges of her condition amidst personal loss. Her story highlights the importance of specialised care, like the new sickle cell clinic, which offers hope and support. Despite hardships, Clemons finds solace in community and work, maintaining resilience.

Neonatal Screening Reduces Sickle Cell Complications in Catalonia

Neonatal screening for Sickle Cell Disease in Catalonia has significantly reduced complications, hospitalisations, and transfusions in children. Early detection and treatment have improved health outcomes, highlighting the programme's success. This initiative offers hope and a model for other regions, potentially saving lives and reducing disease management costs globally.

Promising Developments in Pharma: A Week of Hopeful Progress

Viking Therapeutics shared promising data on VK2738 at ObesityWeek, while Beam Therapeutics reported early-stage results for BEAM-101. Arcus Biosciences and Gilead Sciences announced positive Phase III results for domvanalimab. Novo Nordisk's financial results also drew attention, highlighting significant developments in the pharmaceutical industry.